Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Cell Host & Microbe
|
July 21, 2009
CarD tricks and magic spots: mechanisms of stringent control in mycobacteria
Lynn E Connolly, Jeffery S Cox
Plos Genetics
|
December 17, 2009
Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution
Holly R Ramage, Lynn E Connolly, Jeffery S Cox
Cold Spring Harbor Perspectives in Medicine
|
June 3, 2016
Aminoglycosides: An Overview
Kevin M Krause, Alisa W Serio, Timothy R Kane, et al.
The Journal of Antimicrobial Chemotherapy
|
November 2, 2017
Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates
Valérie Denervaud-Tendon, Laurent Poirel, Lynn E Connolly, et al.
Antimicrobial Agents and Chemotherapy
|
January 31, 2018
A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
Lynn E Connolly, Valerie Riddle, Deborah Cebrik, et al.
Infection and Immunity
|
September 17, 2008
Recombination-based in vivo expression technology identifies Helicobacter pylori genes important for host colonization
Andrea R Castillo, Andrew J Woodruff, Lynn E Connolly, et al.
Infection and Immunity
|
October 24, 2006
Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity
Laura E Swaim, Lynn E Connolly, Hannah E Volkman, et al.
Cell
|
March 8, 2011
Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism
Kristin N Adams, Kevin Takaki, Lynn E Connolly, et al.
The New England Journal of Medicine
|
February 21, 2019
Once-Daily Plazomicin for Complicated Urinary Tract Infections
Florian M E Wagenlehner, Daniel J Cloutier, Allison S Komirenko, et al.
Open Forum Infectious Diseases
|
July 27, 2023
Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE)
Michael G Ison, Debra F Weinstein, Marta Dobryanska, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Cell Host & Microbe
|
July 21, 2009
CarD tricks and magic spots: mechanisms of stringent control in mycobacteria
Lynn E Connolly, Jeffery S Cox
Plos Genetics
|
December 17, 2009
Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution
Holly R Ramage, Lynn E Connolly, Jeffery S Cox
Cold Spring Harbor Perspectives in Medicine
|
June 3, 2016
Aminoglycosides: An Overview
Kevin M Krause, Alisa W Serio, Timothy R Kane, et al.
The Journal of Antimicrobial Chemotherapy
|
November 2, 2017
Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates
Valérie Denervaud-Tendon, Laurent Poirel, Lynn E Connolly, et al.
Antimicrobial Agents and Chemotherapy
|
January 31, 2018
A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
Lynn E Connolly, Valerie Riddle, Deborah Cebrik, et al.
Infection and Immunity
|
September 17, 2008
Recombination-based in vivo expression technology identifies Helicobacter pylori genes important for host colonization
Andrea R Castillo, Andrew J Woodruff, Lynn E Connolly, et al.
Infection and Immunity
|
October 24, 2006
Mycobacterium marinum infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity
Laura E Swaim, Lynn E Connolly, Hannah E Volkman, et al.
Cell
|
March 8, 2011
Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism
Kristin N Adams, Kevin Takaki, Lynn E Connolly, et al.
The New England Journal of Medicine
|
February 21, 2019
Once-Daily Plazomicin for Complicated Urinary Tract Infections
Florian M E Wagenlehner, Daniel J Cloutier, Allison S Komirenko, et al.
Open Forum Infectious Diseases
|
July 27, 2023
Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE)
Michael G Ison, Debra F Weinstein, Marta Dobryanska, et al.
Page
of 2